1621558194 Bharat Biotech targets 1billionyear doses by 2021 end India News
We Care...!!!

Representative picture

HYDERABAD: Amid a rising clamour for ramp-up of Covaxin capability, its developer Bharat Biotech has determined to deploy its Chiron Behring facility in Gujarat to spice up output by one other 200 million doses yearly.
This will scale up manufacturing to just about 1 billion doses a 12 months by 2021 finish, a high Bharat Biotech government stated on Thursday. “The company plans to produce 200 million doses of Covaxin per annum,” Bharat Biotech joint MD Suchitra Ella tweeted in regards to the new facility.

FacebookTwitterLinkedinEMail

Report

Leave a Reply

Your email address will not be published. Required fields are marked *

Translate »